MHRA Approval for First UK-made mRNA Vaccine - Takeaways - MDSpire

MHRA Approval for First UK-made mRNA Vaccine

Moderna receives MHRA approval for updated COVID-19 vaccine targeting SARS-CoV-2 variant LP.8.1

  • February 27, 2026

  • 2 min

Share

  • 1

    The MHRA has authorized Moderna's updated COVID-19 mRNA vaccine, Spikevax®, for adults and children six months and older.

  • 2

    The updated Spikevax® vaccine targets the SARS-CoV-2 LP.8.1 variant and will be supplied for the 2026 NHS COVID-19 vaccination campaign.

  • 3

    Moderna's LP.8.1 vaccine is the first commercially available mRNA vaccine manufactured in the UK, enhancing local vaccine resilience.

  • 4

    The MITC in Harwell, Oxfordshire, supports the UK’s pandemic preparedness through on-shoring vaccine manufacturing and research.

  • 5

    The MHRA's approval aligns with WHO recommendations for updating COVID-19 vaccines, with similar approvals from the FDA and EMA.

Original Source(s)

MHRA Approval for First UK-made mRNA Vaccine

  • February 27, 2026

Related Content

Bereavement Tied to Higher Cardiovascular Risk

Acute post-loss period and pandemic conditions each amplified cardiovascular vulnerability in nationwide Swedish cohort study.

Low Weight Linked to Severe Pediatric COVID

Brazilian pediatric intensive care unit study found underweight status was associated with respiratory complications, longer hospitalization, and mortality among critically ill patients with COVID-19.

RSV Prevention Tied to Lower Infant Acute Care Use

Data suggest fewer respiratory syncytial virus–associated hospitalizations and emergency department visits among the youngest infants during the second season of routine prevention product use.